Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Current Ratio Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Current ratio (current assets / current liabilities)
Latest
26.37
↑ 363% above average
Average (8y)
5.69
Historical baseline
Range
High:26.37
Low:0.01
CAGR
+117.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 26.37 | +538.0% |
| 2023 | 4.13 | -37.3% |
| 2022 | 6.59 | -37.0% |
| 2021 | 10.47 | +234.6% |
| 2020 | 3.13 | +37531.6% |
| 2019 | 0.01 | -97.6% |
| 2018 | 0.35 | +200.9% |
| 2017 | 0.11 | +116.8% |
| 2016 | 0.05 | - |